These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31582656)

  • 1. Hepatocyte-Targeted Delivery of siRNA Polyplex with PEG-Modified Lactosylated Dendrimer/Cyclodextrin Conjugates for Transthyretin-Related Amyloidosis Therapy.
    Hayashi Y; Higashi T; Motoyama K; Jono H; Ando Y; Onodera R; Arima H
    Biol Pharm Bull; 2019; 42(10):1679-1688. PubMed ID: 31582656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and evaluation of polyamidoamine dendrimer conjugate with PEG, α-cyclodextrin and lactose as a novel hepatocyte-selective gene carrier in vitro and in vivo.
    Hayashi Y; Higashi T; Motoyama K; Mori Y; Jono H; Ando Y; Arima H
    J Drug Target; 2013 May; 21(5):487-96. PubMed ID: 23570609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential use of lactosylated dendrimer (G3)/α-cyclodextrin conjugates as hepatocyte-specific siRNA carriers for the treatment of familial amyloidotic polyneuropathy.
    Hayashi Y; Mori Y; Yamashita S; Motoyama K; Higashi T; Jono H; Ando Y; Arima H
    Mol Pharm; 2012 Jun; 9(6):1645-53. PubMed ID: 22510029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic delivery of transthyretin siRNA mediated by lactosylated dendrimer/α-cyclodextrin conjugates into hepatocyte for familial amyloidotic polyneuropathy therapy.
    Hayashi Y; Mori Y; Higashi T; Motoyama K; Jono H; Sah DW; Ando Y; Arima H
    Amyloid; 2012 Jun; 19 Suppl 1():47-9. PubMed ID: 22519861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential use of glucuronylglucosyl-β-cyclodextrin/dendrimer conjugate (G2) as a siRNA carrier for the treatment of familial amyloidotic polyneuropathy.
    Anno T; Higashi T; Hayashi Y; Motoyama K; Jono H; Ando Y; Arima H
    J Drug Target; 2014 Dec; 22(10):883-90. PubMed ID: 25051178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro and In Vivo Tumor-Targeting siRNA Delivery Using Folate-PEG-appended Dendrimer (G4)/α-Cyclodextrin Conjugates.
    Ohyama A; Higashi T; Motoyama K; Arima H
    Bioconjug Chem; 2016 Mar; 27(3):521-32. PubMed ID: 26715308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folate-PEG-appended dendrimer conjugate with α-cyclodextrin as a novel cancer cell-selective siRNA delivery carrier.
    Arima H; Yoshimatsu A; Ikeda H; Ohyama A; Motoyama K; Higashi T; Tsuchiya A; Niidome T; Katayama Y; Hattori K; Takeuchi T
    Mol Pharm; 2012 Sep; 9(9):2591-604. PubMed ID: 22873579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosis.
    Butler JS; Chan A; Costelha S; Fishman S; Willoughby JL; Borland TD; Milstein S; Foster DJ; Gonçalves P; Chen Q; Qin J; Bettencourt BR; Sah DW; Alvarez R; Rajeev KG; Manoharan M; Fitzgerald K; Meyers RE; Nochur SV; Saraiva MJ; Zimmermann TS
    Amyloid; 2016 Jun; 23(2):109-18. PubMed ID: 27033334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leading RNA Interference Therapeutics Part 1: Silencing Hereditary Transthyretin Amyloidosis, with a Focus on Patisiran.
    Titze-de-Almeida SS; Brandão PRP; Faber I; Titze-de-Almeida R
    Mol Diagn Ther; 2020 Feb; 24(1):49-59. PubMed ID: 31701435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo siRNA delivery to hepatocyte utilizing ternary complexation of lactosylated dendrimer/cyclodextrin conjugates, siRNA and low-molecular-weight sacran.
    Hayashi Y; Higashi T; Motoyama K; Jono H; Ando Y; Arima H
    Int J Biol Macromol; 2018 Feb; 107(Pt A):1113-1121. PubMed ID: 28964842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility Study of Dendrimer-Based TTR-CRISPR pDNA Polyplex for Ocular Amyloidosis in Vitro.
    Inoue M; Muta K; Mohammed AFA; Onodera R; Higashi T; Ouchi K; Ueda M; Ando Y; Arima H; Jono H; Motoyama K
    Biol Pharm Bull; 2022; 45(11):1660-1668. PubMed ID: 36328502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver-directed drugs for transthyretin-mediated amyloidosis.
    Brannagan TH; Berk JL; Gillmore JD; Maurer MS; Waddington-Cruz M; Fontana M; Masri A; Obici L; Brambatti M; Baker BF; Hannan LA; Buchele G; Viney NJ; Coelho T; Nativi-Nicolau J
    J Peripher Nerv Syst; 2022 Dec; 27(4):228-237. PubMed ID: 36345805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sugar-appended polyamidoamine dendrimer conjugates with cyclodextrins as cell-specific non-viral vectors.
    Arima H; Motoyama K; Higashi T
    Adv Drug Deliv Rev; 2013 Aug; 65(9):1204-14. PubMed ID: 23602906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of ocular transthyretin, a gene responsible for hereditary transthyretin amyloidosis, by intravitreal injection of an siRNA conjugate into rabbit eyes.
    Watanabe T; Takihara Y; Jono H; Fujimoto T; Tasaki M; Isoguchi A; Urahashi Y; Shimoda T; Takahashi E; Ando Y; Ueno S; Ueda M; Inoue T
    Biochem Biophys Res Commun; 2024 Jan; 694():149397. PubMed ID: 38157582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOE polymorphism in ATTR amyloidosis patients treated with lipid nanoparticle siRNA.
    Niemietz C; Nadzemova O; Zibert A; Schmidt HH
    Amyloid; 2020 Mar; 27(1):45-51. PubMed ID: 31648569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective silencing of a mutant transthyretin allele by small interfering RNAs.
    Kurosawa T; Igarashi S; Nishizawa M; Onodera O
    Biochem Biophys Res Commun; 2005 Nov; 337(3):1012-8. PubMed ID: 16225852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances in Oligonucleotide-Based Therapy for Transthyretin Amyloidosis: Clinical Impact and Future Prospects.
    Hayashi Y; Jono H
    Biol Pharm Bull; 2018; 41(12):1737-1744. PubMed ID: 30504675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patisiran for the treatment of hereditary transthyretin-mediated amyloidosis.
    Yang J
    Expert Rev Clin Pharmacol; 2019 Feb; 12(2):95-99. PubMed ID: 30644768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and evaluation of polyamidoamine dendrimer conjugate with glucuronylglucosyl-β-cyclodextrin (G3) as a novel carrier for siRNA.
    Abdelwahab AF; Ohyama A; Higashi T; Motoyama K; Khaled KA; Sarhan HA; Hussein AK; Arima H
    J Drug Target; 2014 Dec; 22(10):927-34. PubMed ID: 25148608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clusterin regulates transthyretin amyloidosis.
    Lee KW; Lee DH; Son H; Kim YS; Park JY; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi WS
    Biochem Biophys Res Commun; 2009 Oct; 388(2):256-60. PubMed ID: 19664600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.